The International Registry for Alzheimer’s Disease and Other Dementias Foundation (InRAD) would like to thank and acknowledge the following organisations for their early financial contributions:
‍

Eli Lilly and Company Ltd

For their collaborative research agreement to support the data entry portal and registry platform build, medical writing and project management services for Alzheimers Europe 2024, CTAD 2024 and ADPD 2025

‍

Novo Nordisk

For their grant to support medical writing, design and project management services at AAIC 2024

‍
‍